comparemela.com
Home
Live Updates
CStone Announces the First - in - Class Registrational Clini
CStone Announces the First - in - Class Registrational Clini
CStone Announces the First - in - Class Registrational Clinical Trial of Sugemalimab Met its Primary Endpoint in Stage III NSCLC and Plans
... and commercializing innovative immuno - oncology therapies and precision medicines, today ... It has also been granted Breakthrough Therapy Designation by ...
Related Keywords
,
National Medical Products Administration ,
Registrational Clinical Trial ,
Sugemalimab Met ,
Primary Endpoint ,
Breakthrough Therapy Designation ,
Cstone ,
Nnounces ,
The ,
First ,
Glass ,
Registrational ,
Linical ,
Trial ,
Sugemalimab ,
Pet ,
Its ,
Primary ,
Ndpoint ,
Stage ,
Wii ,
Nsclc ,
End ,
Plans ,
ப்ரைமரீ இறுதிப்புள்ளி ,
திருப்புமுனை சிகிச்சை பதவி ,
அவர் ,
ரியால் ,
மற்றும் பலர் ,
ட்ச் ,
தாகே ,
ீ ,
ந்த் ,